Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06559839 · ClinicalTrials.gov registry record · NA
Vestibular Innovation in Pain
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT06559839 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 39 participants.
The verdict
NCT06559839, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The VIP trial will assess the effectiveness, tolerability, and durability of effect of vestibulocortical stimulation (VCS) - a safe \& cost-effective bedside technique - in treating pain, fatigue \& related symptoms using validated patient-reported outcomes. Data from this trial will be used to guide optimized treatment protocols in future randomized controlled trials and help inform the implementation of VCS into standard clinical practice.
Interventions
- OTHER Vestibulocortical Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2025-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06559839
The ClinicalTrials.gov registry entry for NCT06559839 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vestibulocortical Stimulation is the first listed.
NCT06559839 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06559839 about?
NCT06559839 is a clinical study titled "Vestibular Innovation in Pain". The VIP trial will assess the effectiveness, tolerability, and durability of effect of vestibulocortical stimulation (VCS) - a safe \& cost-effective bedside technique - in treating pain, fatigue \& related symptoms using validated patient-reported outcomes. Data from this trial will be used to guid...
What is the current status of trial NCT06559839?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2024-10-01. Estimated completion is 2025-03-06.
What interventions are being tested in trial NCT06559839?
The interventions under investigation include: Vestibulocortical Stimulation (OTHER).
Who is sponsoring clinical trial NCT06559839?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.